[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BowTiedBiotech 🧪🔬🧬 [@BowTiedBiotech](/creator/twitter/BowTiedBiotech) on x 19.7K followers Created: 2025-07-05 11:31:09 UTC 6/ 🧲 M&A Implications This isn’t just about earnings. The overhang froze deals. Now? 🔹 Swiss buyers (Roche, Novartis, Lonza) can get aggressive again in the US 🔹 PE firms may re-enter Swiss CDMO auctions 🔹 Galderma becomes takeout bait for aesthetics roll-ups This clause unlocks cross-border dealmaking. XXX engagements  **Related Topics** [$galdsw](/topic/$galdsw) [$lonnsw](/topic/$lonnsw) [novartis](/topic/novartis) [$novnsw](/topic/$novnsw) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/BowTiedBiotech/status/1941459833493868545)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BowTiedBiotech 🧪🔬🧬 @BowTiedBiotech on x 19.7K followers
Created: 2025-07-05 11:31:09 UTC
6/ 🧲 M&A Implications
This isn’t just about earnings.
The overhang froze deals. Now?
🔹 Swiss buyers (Roche, Novartis, Lonza) can get aggressive again in the US
🔹 PE firms may re-enter Swiss CDMO auctions
🔹 Galderma becomes takeout bait for aesthetics roll-ups
This clause unlocks cross-border dealmaking.
XXX engagements
Related Topics $galdsw $lonnsw novartis $novnsw stocks healthcare
/post/tweet::1941459833493868545